Alexo Begins Testing ALX148 Combinations in Phase 1 Trial of NHL, Solid Tumors
News
Alexo Therapeutics has started treating patients in the combination part of its Phase 1 trial, which will test multiple combinations of ALX148 with targeted antibody therapies — including Keytruda (pembrolizumab), Herceptin ... Read more